SE469473B - Vasoaktiva peptider - Google Patents

Vasoaktiva peptider

Info

Publication number
SE469473B
SE469473B SE8703855A SE8703855A SE469473B SE 469473 B SE469473 B SE 469473B SE 8703855 A SE8703855 A SE 8703855A SE 8703855 A SE8703855 A SE 8703855A SE 469473 B SE469473 B SE 469473B
Authority
SE
Sweden
Prior art keywords
hydroxy
acid residue
mercaptopropionic acid
amino acids
same
Prior art date
Application number
SE8703855A
Other languages
English (en)
Swedish (sv)
Other versions
SE8703855L (sv
SE8703855D0 (sv
Inventor
P Melin
J Trojnar
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8703855A priority Critical patent/SE469473B/sv
Publication of SE8703855D0 publication Critical patent/SE8703855D0/xx
Priority to PCT/SE1988/000509 priority patent/WO1989003393A1/en
Priority to DE88908781T priority patent/DE3882233T2/de
Priority to AT88908781T priority patent/ATE91286T1/de
Priority to JP63508061A priority patent/JPH03500409A/ja
Priority to AU25339/88A priority patent/AU606476B2/en
Priority to EP88908781A priority patent/EP0380554B1/de
Publication of SE8703855L publication Critical patent/SE8703855L/xx
Priority to NO901558A priority patent/NO901558D0/no
Priority to DK087090A priority patent/DK87090A/da
Priority to FI901773A priority patent/FI901773A0/fi
Publication of SE469473B publication Critical patent/SE469473B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8703855A 1987-10-07 1987-10-07 Vasoaktiva peptider SE469473B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8703855A SE469473B (sv) 1987-10-07 1987-10-07 Vasoaktiva peptider
EP88908781A EP0380554B1 (de) 1987-10-07 1988-10-04 Gefässaktive peptide
JP63508061A JPH03500409A (ja) 1987-10-07 1988-10-04 血管作動性ペプチド
DE88908781T DE3882233T2 (de) 1987-10-07 1988-10-04 Gefässaktive peptide.
AT88908781T ATE91286T1 (de) 1987-10-07 1988-10-04 Gefaessaktive peptide.
PCT/SE1988/000509 WO1989003393A1 (en) 1987-10-07 1988-10-04 Vasoactive peptides
AU25339/88A AU606476B2 (en) 1987-10-07 1988-10-04 Vasoactive peptides
NO901558A NO901558D0 (no) 1987-10-07 1990-04-05 Vasoaktive peptider.
DK087090A DK87090A (da) 1987-10-07 1990-04-06 Vasotocin-derivater og farmaceutiske midler indeholdende saadanne derivater
FI901773A FI901773A0 (fi) 1987-10-07 1990-04-06 Vasoaktiva peptider.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8703855A SE469473B (sv) 1987-10-07 1987-10-07 Vasoaktiva peptider

Publications (3)

Publication Number Publication Date
SE8703855D0 SE8703855D0 (sv) 1987-10-07
SE8703855L SE8703855L (sv) 1989-04-08
SE469473B true SE469473B (sv) 1993-07-12

Family

ID=20369772

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703855A SE469473B (sv) 1987-10-07 1987-10-07 Vasoaktiva peptider

Country Status (10)

Country Link
EP (1) EP0380554B1 (de)
JP (1) JPH03500409A (de)
AT (1) ATE91286T1 (de)
AU (1) AU606476B2 (de)
DE (1) DE3882233T2 (de)
DK (1) DK87090A (de)
FI (1) FI901773A0 (de)
NO (1) NO901558D0 (de)
SE (1) SE469473B (de)
WO (1) WO1989003393A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
WO2009037586A2 (en) 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129421C (de) * 1963-08-30 1900-01-01
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden

Also Published As

Publication number Publication date
EP0380554B1 (de) 1993-07-07
ATE91286T1 (de) 1993-07-15
FI901773A0 (fi) 1990-04-06
SE8703855L (sv) 1989-04-08
NO901558L (no) 1990-04-05
NO901558D0 (no) 1990-04-05
DK87090D0 (da) 1990-04-06
WO1989003393A1 (en) 1989-04-20
SE8703855D0 (sv) 1987-10-07
DK87090A (da) 1990-06-01
EP0380554A1 (de) 1990-08-08
JPH03500409A (ja) 1991-01-31
DE3882233T2 (de) 1993-10-21
DE3882233D1 (de) 1993-08-12
AU606476B2 (en) 1991-02-07
AU2533988A (en) 1989-05-02

Similar Documents

Publication Publication Date Title
JPS62159B2 (de)
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5204328A (en) Peptides having atrial natriuretic factor activity
AU6751290A (en) Synthetic calcitonin peptides
JP2837352B2 (ja) 胃腸運動活性を抑制するモチリン類似ポリペプチド
EP0363589A2 (de) Somatostatin-Analoge
JPS6396199A (ja) バソプレシン拮抗剤
SE501677C2 (sv) Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
WO2024098718A1 (zh) 一种新型长效多肽化合物、组合物及其应用
EP0517778B1 (de) Vasoaktive derivate des vasotocins
SE469473B (sv) Vasoaktiva peptider
JPH0592996A (ja) 心房性ナトリウム利尿因子活性をもつペプチド
US4597901A (en) β-indolylalanyl or β-indolylglycinyl vasopressin antagonists
EP0431113A1 (de) Atriale peptidderivate
Feinstein et al. Structural requirements for neuropeptide Y18-36-evoked hypotension: a systematic study
AU703400B2 (en) Antagonists of LHRH
KR0141973B1 (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
US4719199A (en) Diuretic compositions and methods of producing diuresis
US4684716A (en) Polypeptide intermediates
Biondi et al. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N‐alkylglycine in place of residues in position 1, 3, 5 and 6
JPS63225399A (ja) ペプチド誘導体およびその製造法
Śleszyńska et al. New bradykinin B2 receptor antagonists-influence of C-terminal segment modifications on their pharmacological properties
BJÖRKROTH et al. Synthesis of Substance P Analogs and Agonistic and Antagonistic Activities

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8703855-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8703855-0

Format of ref document f/p: F